Abstract:Background Epidemiological surveys have revealed that low serum vitamin D level was correlated with increased risk of tumors. Dysfunctional T cells in patients with tumor are characterized as exhausted with high levels of immune checkpoint receptors (ICRs). However, whether the reduced level of vitamin D in patients with cancer correlates with cytotoxic T-cell exhaustion is unknown. Methods Periphery blood samples from 172 patients with non-small cell lung cancer (NSCLC) were prospectively collected. Patients with NSCLC received one course of intravenous docetaxel (75 mg/m 2 ) followed by treatment with or without rocaltrol at a dose of 0.5–2.0 μg/day for total of 3 weeks. We performed phenotypical and functional analysis of T-cell through flow cytometry. Vitamin D receptor (VDR) knockout and overexpression CD8 + and Vδ2 + T cells were constructed using Cas9-gRNA targeted and overexpressing approaches to identify 1α,25(OH) 2 D 3 /VDR-mediated transcription regulation for ICRs or antitumor activity in T cells. Results We show that serum level of vitamin D is negatively correlated with expression of programmed cell death-1 (PD-1), T-cell immunoreceptor with Ig and ITIM domains (TIGIT), and T-cell immunoglobulin and mucin-domain containing-3 (Tim-3), but positively correlated with CD28 expression on CD8 + and Vγ9Vδ2 + T cells in patients with NSCLC. 1α,25(OH) 2 D 3 , the active form of vitamin D, promotes the nuclear translocation of VDR, which binds to the promoter region of Pdcd1 , Tim3 , and Tigit genes and inhibits their expression. Besides, 1α,25(OH) 2 D 3 pretreatment also promotes the methylation of CpG island in the promoter region of the Pdcd1 gene and increases H3K27 acetylation at the promoter region of the Cd28 gene, which leads to surface PD-1 downregulation and CD28 upregulation, respectively. We further reveal that VDR-mediated Ca 2+ influx enhanced expression of Th1 cytokines via T-cell receptor activation. Functionally, 1α,25(OH) 2 D 3 pretreated CD8 + T cells or Vγ9Vδ2 + T cells showed increased Th1 cytokine production and enhanced antitumor immunity. Finally, oral 1α,25(OH) 2 D 3 could also decrease expression of PD-1, Tim-3, TIGIT and increase expression of CD28, resulting in cytokine production (associated with antitumor immunity) by cytotoxic T cells of patients with NSCLC. Conclusions Our findings uncover the pleiotropic effects of 1α,25(OH) 2 D 3 in rescuing the exhausted phenotype of human cytotoxic T cells in patients with tumor and in promoting their antitumor immunity. Trial registration number ChiCTR2100051135.

Tumor-suppressive Effects of 1, 25-Dihydroxyvitamin D3 in Gastric Cancer Cells.

1 α ,25 (OH)2D3 inhibits proliferation of gastric cancer cell line by arresting cell cycle

1,25-Dihydroxyvitamin D3 Affects Gastric Cancer Progression by Repressing BMP3 Promoter Methylation.

1,25-Dihydroxyvitamin D3 and Cisplatin Synergistically Induce Apoptosis and Cell Cycle Arrest in Gastric Cancer Cells

Vitamin D3 promotes gastric cancer cell autophagy by mediating p53/AMPK/mTOR signaling

Prognostic Effects of 25-Hydroxyvitamin D Levels in Gastric Cancer.

Vitamin D suppressed gastric cancer cell growth through downregulating CD44 expression in vitro and in vivo

1Α,25(oh)2d3 Reverses Exhaustion and Enhances Antitumor Immunity of Human Cytotoxic T Cells.

226 THE PROGNOSTIC SIGNIFICANCE OF PREOPERATIVE SERUM LEVELS OF EXTRACELLULAR MATRIX PROTEIN 1 IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

Vitamin D, Intermediary Metabolism and Prostate Cancer Tumor Progression

Antiproliferative Effects of 1α,25-Dihydroxyvitamin D3 and Vitamin D Analogs on Tumor-Derived Endothelial Cells

1Α,25(oh) 2D 3 Decreases Expression of Immune Checkpoint Receptors and Enhances Anti-Tumor Immunity of Human Cytotoxic T Cells

Anti-proliferative and Apoptotic Effects of S1, a Tetrandrine Derivative, in Human Gastric Cancer BGC-823 Cells

The effect of 1，25-dihydroxyvitamin D3 on matrix Gla protein and Wnt/β-catenin signaling pathways in human osteosarcoma MG63 cells line

1α,25(OH) 2 D 3 reverses exhaustion and enhances antitumor immunity of human cytotoxic T cells

Inhibitory Effect of 1,25(OH)2D3 on Proliferation of Human Laryngeal Carcinoma Cells and Potential Mechanisms

Inhibition of Proliferation and Induction of Apoptosis by the Combination of Β-Carotene and 1,25-Dihydroxyvitamin D3 in Human Esophageal Cancer EC9706 Cells

20-hydroxyvitamin D₃ inhibits proliferation of cancer cells with high efficacy while being non-toxic.

Effect of 1,25(OH)2 vitamin D3 on the sensitivities of breast cancer cells to ionizing radiation

1Α,25(oh)2d3 Radiosensitizes Cancer Cells by Activating the NADPH/ROS Pathway.

miR-145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells.